Joined Today: 3

MDVN Medeivation, Stock Message Board

All Messages

#3: Pfizer and Medivation Enter into Global Agreement to Co-Develop and Market Dimebon for the Treatment of Alzheimer's and Huntington's Diseases
TheMachine	September 20, 2008 02:44:17 AM
Medivation to Host Conference Call/Webcast Today at 8:30 a.m. Eastern Time Pfizer Inc (NYSE: PFE) and Medivation, Inc.(NASDAQ: MDVN) announced today that... view message ignore post recommend post

#2: profile
FastFun	November 27, 2007 11:01:37 PM
Medivation, Inc. is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively. Medivation's current... view message ignore post recommend post

#1: MDVN, Medivation's Dimebon(TM) Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimer's Disease Trial After One Year of Therapy
Jason	June 21, 2007 05:23:39 PM
- Aggregate Benefit over Placebo Larger at One Year than at Six Months - - Dimebon-Treated Patients Stabilized for a Full Year - - Conference Call Scheduled for Today at 8:30 a.m. Eastern Time... view message ignore post recommend post

Group Home | Login if you want to post a message